Prometheus Launches New Indication for PredictrPK® IFX, A Precision-Guided Dosing Test for IBD

PredictrPK IFX is now available for both the induction and maintenance phases of infliximab (IFX) therapy for inflammatory bowel disease (IBD) patients PredictrPK IFX addresses the unmet need of personalized early IFX optimization to support therapeutic response, drug durability and…